Evidence map›Paper›PMID 25623945›Full record

ArticleMolecular psychiatry2015

Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes.

J A Brown, T S Ramikie, M J Schmidt, R Báldi, K Garbett, M G Everheart, L E Warren, L Gellért, S Horváth, S Patel and 1 more

Abstract read
In one paragraph

Article in Molecular psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 107 citations in OpenAlex.

  1. Identification of somatostatinProceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Beyond the γ-aminobutyric acid hypothesis of schizophrenia.Frontiers in cellular neuroscience · 2023
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Chemogenetic Activation of Cortical Parvalbumin-Positive Interneurons Reverses Noise-Induced Impairments in Gap Detection.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

J A BrownDepartment of Psychiatry, Psychiatry and Kennedy Center, Vanderbilt University, Nashville, TN, USA.
T S RamikieDepartment of Psychiatry, Psychiatry and Kennedy Center, Vanderbilt University, Nashville, TN, USA.
M J SchmidtDepartment of Psychiatry, Psychiatry and Kennedy Center, Vanderbilt University, Nashville, TN, USA.
R BáldiDepartment of Psychiatry, Psychiatry and Kennedy Center, Vanderbilt University, Nashville, TN, USA.
K GarbettDepartment of Psychiatry, Psychiatry and Kennedy Center, Vanderbilt University, Nashville, TN, USA.
M G EverheartDepartment of Psychiatry, Psychiatry and Kennedy Center, Vanderbilt University, Nashville, TN, USA.
L E WarrenVanderbilt Kennedy Center for Research on Human Development, Vanderbilt University, Nashville, TN, USA.
L GellértDepartment of Psychiatry, University of Szeged, Szeged, Hungary.
S HorváthDepartment of Psychiatry, Psychiatry and Kennedy Center, Vanderbilt University, Nashville, TN, USA.
S PatelDepartment of Psychiatry, Psychiatry and Kennedy Center, Vanderbilt University, Nashville, TN, USA.
Károly MirnicsDepartment of Psychiatry, Psychiatry and Kennedy Center, Vanderbilt University, Nashville, TN, USA.
Vanderbilt University · USJohn F. Kennedy Center for the Performing Arts · USUniversity of Szeged · HU

Funding

THREE-TIERED PREVENTION MODEL TO BETTER SERVE ALL STUDENP30HD015052 · NICHD · VANDERBILT UNIVERSITY · PI DYKENS, ELISABETH MAY · 1985 to 2014
$18.6M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Program in NeurogenomicsT32MH065215 · NIMH · VANDERBILT UNIVERSITY · PI ROGER J COLBRAN · 2002 to 2026
$6.4M
Neocortical Transcriptome Changes in SchizophreniaR01MH067234 · NIMH · VANDERBILT UNIVERSITY · PI MIRNICS, KAROLY · 2003 to 2021
$4.7M
Neuroimmune Changes in SchizophreniaR01MH079299 · NIMH · VANDERBILT UNIVERSITY · PI MIRNICS, KAROLY · 2007 to 2011
$1.7M
Stress adaptations in endocannabinoid signaling in the amygdalaK08MH090412 · NIMH · VANDERBILT UNIVERSITY · PI PATEL, SACHIN · 2010 to 2014
$842k
Afferent-specific Endocannabinoid Signaling in the Central AmygdalaR21MH103515 · NIMH · VANDERBILT UNIVERSITY · PI PATEL, SACHIN · 2014 to 2015
$412k
NICHD NIH HHS P30 HD015052NICHD NIH HHS P30 HD15052NICHD NIH HHS U54 HD083211NIMH NIH HHS 2T32MH065215-11NIMH NIH HHS K08 MH090412NIMH NIH HHS R01 MH067234NIMH NIH HHS R01 MH079299NIMH NIH HHS R01 R21-MH103515NIMH NIH HHS R21 MH103515NIMH NIH HHS T32 MH065215
6 · The paper itself

Abstract

Reduced expression of the Gad1 gene-encoded 67-kDa protein isoform of glutamic acid decarboxylase (GAD67) is a hallmark of schizophrenia. GAD67 downregulation occurs in multiple interneuronal sub-populations, including the parvalbumin-positive (PVALB+) cells. To investigate the role of the PV-positive GABAergic interneurons in behavioral and molecular processes, we knocked down the Gad1 transcript using a microRNA engineered to target specifically Gad1 mRNA under the control of Pvalb bacterial artificial chromosome. Verification of construct expression was performed by immunohistochemistry. Follow-up electrophysiological studies revealed a significant reduction in γ-aminobutyric acid (GABA) release probability without alterations in postsynaptic membrane properties or changes in glutamatergic release probability in the prefrontal cortex pyramidal neurons. Behavioral characterization of our transgenic (Tg) mice uncovered that the Pvalb/Gad1 Tg mice have pronounced sensorimotor gating deficits, increased novelty-seeking and reduced fear extinction. Furthermore, NMDA (N-methyl-d-aspartate) receptor antagonism by ketamine had an opposing dose-dependent effect, suggesting that the differential dosage of ketamine might have divergent effects on behavioral processes. All behavioral studies were validated using a second cohort of animals. Our results suggest that reduction of GABAergic transmission from PVALB+ interneurons primarily impacts behavioral domains related to fear and novelty seeking and that these alterations might be related to the behavioral phenotype observed in schizophrenia.

Indexed as

Behavior, AnimalAnimalsBrainDisease Models, AnimalElectrophysiologyExploratory BehaviorFearGene SilencingGlutamate DecarboxylaseInterneuronsKetamineMaleMiceMice, Inbred C3HMice, TransgenicParvalbuminsGlutamate Decarboxylaseglutamate decarboxylase 1KetamineParvalbuminsReceptors, N-Methyl-D-Aspartate

Identifiers

PMID25623945
PMCPMC4516717
OpenAlexW2019945509

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.